Research Solutions

The nanoverita™ instrument. The closed chip is designed to deliver sample-to-answer workflow and accommodates safe disposal of biohazard materials.

The nanoverita™ instrument. The closed chip is designed to deliver sample-to-answer workflow and accommodates safe disposal of biohazard materials.

NanoVerita™ System

The NanoVerita™ instrument lab-on-a-chip system is designed to deliver a sample-to-answer workflow for isolation and fluorescent imaging of macromolecular targets (e.g. cell-free DNA).

The NanoVerita™ system is built upon the same novel ACE platform that powers Biological Dynamics’ clinical diagnostic program and consists of an automated benchtop instrument and 8 channel consumable cartridge. The system interacts with nanoparticles via an ACE interface that allows for direct isolation of nanoparticles (diameter of ~40-500 nm) without the need to dilute physiological samples, such as plasma or serum.


The ExoVerita™ development platform. The open chip design allows use of multiple wash buffers and detection reagents, as well as elution of molecules following capture.

The ExoVerita™ development platform. The open chip design allows use of multiple wash buffers and detection reagents, as well as elution of molecules following capture.

ExoVerita™ System

The ExoVerita™ instrument is a flexible lab-on-a-chip system designed to support development of assays based on exosomes, cfDNA, and other extracellular vesicles.  The ExoVerita™ system is also built upon the ACE platform and uses an ACE chip to reversibly capture macromolecules in biofluids, such as whole blood, serum, and plasma, enabling both on-chip detection of targets and downstream analysis, such as sequencing and PCR.

The ExoVerita™ system enables a simplified, no-dilution workflow for the development of exosome-based assays, bypassing many fundamental limitations of current isolation technologies. The system is currently being used for internal development purposes. As part of our early technology access program, an optimized benchtop version will be available to select partners to develop the next generation of highly accurate diagnostic solutions.